Cita APA

Horiuchi, D., Kusdra, L., Huskey, N. E., Chandriani, S., Lenburg, M. E., Gonzalez-Angulo, A. M., . . . Goga, A. (2012). MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. The Rockefeller University Press.

Chicago Style Citation

Horiuchi, Dai, et al. MYC Pathway Activation in Triple-negative Breast Cancer Is Synthetic Lethal With CDK Inhibition. The Rockefeller University Press, 2012.

Cita MLA

Horiuchi, Dai, et al. MYC Pathway Activation in Triple-negative Breast Cancer Is Synthetic Lethal With CDK Inhibition. The Rockefeller University Press, 2012.